Hims Hers Health is trading 4.63% up at $30.03 on September 30, 2026, with no clear catalyst identified. - Available searches did not identify a company-specific announcement or reliable report linking a catalyst to the move; recent coverage instead discusses older regulatory and billing scrutiny, not a new development today. - The supplied sector context shows healthcare down, while major indices are mixed; neither clearly explains the gain.